Applicability of monoclonal antibody Fab fragments as a carrier of neocarzinostatin in targeting chemotherapy

Journal of Surgical Oncology

Volumn 61, Issue 2, 1996, Pages 149-154

  Otsuji, Eigo ^a   Yamaguchi, Toshiharu ^a   Tsuruta, Hiroshi ^a   Yata, Yoshihiro ^a   Nishi, Hiroshi ^a   Okamoto, Kazuma ^a   Taniguchi, Katsunori ^a   Kato, Makoto ^a   Kotani, Tatsuya ^a   Kitamura, Kazuya ^a   Takahashi, Toshio ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

F(ab')2 fragment; Fab fragment; monoclonal antibody A7; neocarzinostatin; pancreatic cancer; targeting chemotherapy

Indexed keywords

ANTIBODY CONJUGATE; DRUG CARRIER; IMMUNOGLOBULIN F(AB')2 FRAGMENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A7; UNCLASSIFIED DRUG; ZINOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CANCER CELL DESTRUCTION; CANCER LOCALIZATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG TARGETING; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FAB FRAGMENTS; IODINE RADIOISOTOPES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED; ZINOSTATIN;

EID: 9044226134     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199602)61:2<149::AID-JSO11>3.0.CO;2-4     Document Type: Article

References (24)

1. Houghton AN, Minitzer D, Cordon CC, et al.: Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase 1 trial in patients with malignant melanoma. Proc Natl Acad Sci USA 82:1242-1246, 1985.
2. Meeker TC, Lowder J, Maloney DG, et al.: Clinical trial of antiidiotype therapy for B-cell malignancy. Blood 65:1345-1363, 1985.
3. Miller RA, Maloney DG, Warnke R, et al.: Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med 306:517, 1982.
4. Köhler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497, 1975.
5. Deguchi T, Ming C, Susan SL, et al.: Potential therapeutic effect of adriamycin-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor. J Urol 137:353-358, 1987.
6. Lynn DA, Dianna LZ, Stephan LB, Thomas FB: Antitumor activity of monoclonal antibody-Vinca alkaloid immunoconjugate LY203725 (KS1/4-4-desacetylvinblastine-3-carboxhydrazide) in a nude mouse model of human ovarian cancer. Cancer Res 50:3540-3544, 1990.
7. Ohyanagi H, Ishida H, Ishida T, et al.: A monoclonal antibody, KM10 reactive with human gastrointestinal cancer and its application for immunotherapy. Jpn J Cancer Res 79:1349-1358, 1988.
8. Kotanagi H, Takahashi T, Masuko Y, et al.: A monoclonal antibody against human colon cancers. Tohoku J Exp Med 148:353-360, 1986.
9. Fukuda K: The study of targeting chemotherapy against gastrointestinal cancer. Akita J Med 12:451-468, 1985.
10. Takahashi T, Yamaguchi T, Kitamura K, et al.: Follow-up study of patients treated with monoclonal antibody-drug conjugate: Report of 77 cases with colorectal cancer. Jpn J Cancer Res 84:976-981, 1993.
11. Otsuji E, Yamaguchi Y, Yanamaguchi N, et al.: Expression of the cell surface antigen detected by the monoclonal antibody A7 in pancreatic carcinoma cell lines. Surg Today 22:351-356, 1992.
12. Otsuji E, Yamaguchi T, Yamaoka N, et al.: Increased antitumor effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma grafted in nude mice. Antibody Immunoconjugates Radiopharmac 6:177-183, 1993.
13. 2 and Fab fragments in mice with colon carcinoma xenografts. Eur J Nucl Med 12:167-175, 1986.
14. 111In. Cancer Res 47:1149-1154, 1987.
15. Otsuji E, Takahashi T, Yamaguchi T, et al.: Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma. Gastroenterol Jpn 25:244-248, 1990.
16. 2 fragmentation in athymic nude mice bearing human pancreatic carcinomas. J Surg Oncol 53:168-174, 1993.
17. Otsuji E, Yamaguchi T, Yamaoka N, et al.: Enhanced tumor localization of radiolabeled Fab fragments of monoclonal antibody A7 in nude mice bearing human pancreatic carcinoma xenografts. Jpn J Cancer Res 84:914-920, 1993.
18. 131I-labelled human growth hormone of high specific activity. Nature 194:495-496, 1962.
19. Fujita H, Nakayama N, Sawabe T, Kimura K: In vivo distribution and inactivation of neocarzinostatin. Jpn J Antibiot 23:471-478, 1970.
20. Hansson Y, Paulie S, Ben-Aissa H, et al.: Radioimmunolocalization of bladder tumors xenotransplanted in nude mice. Anticancer Res 8:435-442, 1988.
21. Frodin JE, Biberfeld P, Christensson B, et al.: Treatment of patients with metastasizing colo-rectal carcinoma with mouse monoclonal antibodies: A progress report. Hybridoma 5:S151-S161, 1986.
22. LoBuglio AF, Saleh M, Peterson L, et al.: Phase 1 clinical trial of CO17-1A monoclonal antibody. Hybridoma 5:S117-S123, 1986.
23. Blottiere HM, Maurel C, Douillard JY: Immune function of patients with gastrointestinal carcinoma after treatment with multiple infusions of monoclonal antibody 17.1A. Cancer Res 47:5238-5241, 1987.
24. Spiegelberg HL, Weigle WO: The catabolism of homologous and heterologous 7s gamma globulin fragments. J Exp Med 121:323-338, 1965.